Hypertension awareness, treatment and control in Africa: a systematic review

James Kayima, Rhoda K Wanyenze, Achilles Katamba, Elli Leontsini, Fred Nuwaha, James Kayima, Rhoda K Wanyenze, Achilles Katamba, Elli Leontsini, Fred Nuwaha

Abstract

Background: Inadequate diagnosis and suboptimal control of hypertension is a major driver of cardiovascular morbidity and mortality in Africa. Understanding the levels of awareness, treatment and control of hypertension and the associated factors has important implications for hypertension control efforts.

Methods: The PubMed database was searched for original articles related to awareness, treatment and control of hypertension in Africa published between 1993 and 2013. The key search terms were: Africa, awareness, treatment, control, and hypertension. Exploration of bibliographies cited in the identified articles was done to provide further studies. Full texts of the articles were obtained from various internet sources and individual authors. A data extraction sheet was used to collect this information.

Results: Thirty-eight studies drawn from 23 African countries from all regions of the continent met the inclusion criteria. The levels of awareness, treatment and control varied widely from country to country. Rural populations had lower levels of awareness than urban areas. North African countries had the highest levels of treatment in the continent. There was generally poor control of hypertension across the region even among subjects that were aware of their status and those that were treated. On the whole, the women had a better control status than the men.

Conclusion: There are low levels of awareness and treatment of hypertension and even lower levels of control. Tailored research is required to uncover specific reasons behind these low levels of awareness and treatment, and especially control, in order to inform policy formulation for the improvement of outcomes of hypertensive patients in Africa.

Figures

Figure 1
Figure 1
Flow chart of literature search.
Figure 2
Figure 2
Map of Africa distribution of studies reviewed.

References

    1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547–3553. doi: 10.1161/CIRCULATIONAHA.105.591792.
    1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi: 10.1016/S0140-6736(06)68770-9.
    1. Alwan A. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
    1. Unwin N. Commentary. Non-communicable disease and priorities for health policy in sub-Saharan Africa. Health policy and planning. 2001;16(4):351. doi: 10.1093/heapol/16.4.351.
    1. Bertrand E. Cardiovascular Disease in Developing Countries. New York, NY: McGraw-Hill; 1999.
    1. Brundtland GH. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
    1. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. Journal of hypertension. 2009;27(7):1472. doi: 10.1097/HJH.0b013e32832a9ba3.
    1. Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010;23(1):38–45. doi: 10.1038/ajh.2009.191.
    1. He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens. 2003;17(7):455–457. doi: 10.1038/sj.jhh.1001581.
    1. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50(2):272–298.
    1. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials: blood pressure lowering treatment trialists’ collaboration. Lancet. 2000;356(9246):1955–1964.
    1. Addo J, Smeeth L, Leon DA. Hypertension in Sub-Saharan Africa. Hypertension. 2007;50(6):1012–1018. doi: 10.1161/HYPERTENSIONAHA.107.093336.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. doi: 10.7326/0003-4819-151-4-200908180-00135.
    1. Solet JL, Baroux N, Pochet M, Benoit-Cattin T, De Montera AM, Sissoko D. et al.Prevalence of type 2 diabetes and other cardiovascular risk factors in Mayotte in 2008: the MAYDIA study. Diabetes Metab. 2011;37(3):201–207. doi: 10.1016/j.diabet.2010.09.007.
    1. Mufunda J, Mebrahtu G, Usman A, Nyarango P, Kosia A, Ghebrat Y. et al.The prevalence of hypertension and its relationship with obesity: results from a national blood pressure survey in Eritrea. J Hum Hypertens. 2006;20(1):59–65. doi: 10.1038/sj.jhh.1001924.
    1. Muluneh AT, Haileamlak A, Tessema F, Alemseged F, Woldemichael K, Asefa M. et al.Population based survey of chronic non-communicable diseases at gilgel gibe field research center, southwest Ethiopia. Ethiop J Health Sci. 2012;22(S):7–18.
    1. Awoke A, Awoke T, Alemu S, Megabiaw B. Prevalence and associated factors of hypertension among adults in Gondar, Northwest Ethiopia: a community based cross-sectional study. BMC Cardiovasc Disord. 2012;12(113):1471–2261.
    1. Tesfaye F, Byass P, Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord. 2009;9(39):1471–2261.
    1. van de Vijver SJ, Oti SO, Agyemang C, Gomez GB, Kyobutungi C. Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens. 2013;19:19.
    1. Jenson A, Omar AL, Omar MA, Rishad AS, Khoshnood K. Assessment of hypertension control in a district of Mombasa Kenya. Glob Public Health. 2011;6(3):293–306. doi: 10.1080/17441692.2010.510478.
    1. Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, de Beer IH. et al.Hypertension in Sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One. 2012;7(3):12.
    1. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N. Hypertension prevalence, awareness, treatment, and control in mozambique: urban/rural gap during epidemiological transition. Hypertension. 2009;54(1):77–83. doi: 10.1161/HYPERTENSIONAHA.109.132423.
    1. Bovet P. The epidemiologic transition to chronic diseases in developing countries: cardiovascular mortality, morbidity, and risk factors in Seychelles (Indian Ocean): investigators of the Seychelles heart study. Soz Praventivmed. 1995;40(1):35–43.
    1. Bovet P, Ross AG, Gervasoni JP, Mkamba M, Mtasiwa DM, Lengeler C. et al.Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. Int J Epidemiol. 2002;31(1):240–247. doi: 10.1093/ije/31.1.240.
    1. Dewhurst MJ, Dewhurst F, Gray WK, Chaote P, Orega GP, Walker RW. The high prevalence of hypertension in rural-dwelling Tanzanian older adults and the disparity between detection, treatment and control: a rule of sixths? J Hum Hypertens. 2012;13(10):59.
    1. Edwards R, Unwin N, Mugusi F, Whiting D, Rashid S, Kissima J. et al.Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000;18(2):145–152. doi: 10.1097/00004872-200018020-00003.
    1. Musinguzi G, Nuwaha F. Prevalence awareness and control of hypertension in Uganda. PloS one. 2013;4:e62236.
    1. Pires JE, Sebastiao YV, Langa AJ, Nery SV. Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control. BMC Publ Health. 2013;13(1):90. doi: 10.1186/1471-2458-13-90.
    1. Kamadjeu RM, Edwards R, Atanga JS, Unwin N, Kiawi EC, Mbanya JC. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon burden of diabetes baseline survey. J Hum Hypertens. 2006;20(1):91–92. doi: 10.1038/sj.jhh.1001936.
    1. Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam Kouam C. et al.Prevalence, awareness, treatment and control of hypertension in a self-selected Sub-Saharan African urban population: a cross-sectional study. BMJ Open. 2012;2(4):2012–001217.
    1. Katchunga PB, M’Buyamba-Kayamba JR, Masumbuko BE, Lemogoum D, Kashongwe ZM, Degaute JP. et al.Hypertension in the adult Congolese population of Southern Kivu: results of the vitaraa study. Presse Med. 2011;40(6):3.
    1. Ngoungou EB, Aboyans V, Kouna P, Makandja R, Ecke Nzengue JE, Allogho CN. et al.Prevalence of cardiovascular disease in Gabon: a population study. Arch Cardiovasc Dis. 2012;105(2):77–83. doi: 10.1016/j.acvd.2011.12.005.
    1. Matenga JA, Allain TJ, Wilson AO, Adamchak DJ, Senzanje B, Mushangi E. et al.Hypertension management in Zimbabwe–awareness, treatment and blood pressure control: a community-based study. S Afr Med J. 1997;87(10):1371–1373.
    1. Temmar M, Labat C, Benkhedda S, Charifi M, Thomas F, Bouafia MT. et al.Prevalence and determinants of hypertension in the Algerian Sahara. J Hypertens. 2007;25(11):2218–2226. doi: 10.1097/HJH.0b013e3282dc7549.
    1. Nejjari C, Arharbi M, Chentir MT, Boujnah R, Kemmou O, Megdiche H. et al.Epidemiological trial of hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens. 2013;31(1):49–62.
    1. Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, Helmy S, Sharaf Y. et al.Hypertension prevalence, awareness, treatment, and control in Egypt. results from the Egyptian national hypertension project (NHP). NHP investigative team. Hypertension. 1995;26(6 Pt 1):886–890.
    1. Ben Romdhane H, Ben Ali S, Skhiri H, Traissac P, Bougatef S, Maire B. et al.Hypertension among Tunisian adults: results of the TAHINA project. Hypertens Res. 2012;35(3):341–347. doi: 10.1038/hr.2011.198.
    1. Ben Romdhane H, Skhiri H, Bougatef S, Ennigrou S, Gharbi D, Chahed MK. et al.Hypertension prevalence, awareness, treatment and control: results from a community based survey. Tunis Med. 2005;5:41–46.
    1. Hammami S, Mehri S, Hajem S, Koubaa N, Frih MA, Kammoun S. et al.Awareness, treatment and control of hypertension among the elderly living in their home in Tunisia. BMC Cardiovasc Disord. 2011;11(65):1471–2261.
    1. Houinato DS, Gbary AR, Houehanou YC, Djrolo F, Amoussou M, Segnon-Agueh J. et al.Prevalence of hypertension and associated risk factors in Benin. Rev Epidemiol Sante Publique. 2012;60(2):95–102. doi: 10.1016/j.respe.2011.09.010.
    1. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2006;20(1):67–71. doi: 10.1038/sj.jhh.1001923.
    1. Addo J, Amoah AG, Koram KA. The changing patterns of hypertension in Ghana: a study of four rural communities in the Ga District. Ethn Dis. 2006;16(4):894–899.
    1. Amoah AG. Hypertension in Ghana: a cross-sectional community prevalence study in greater Accra. Ethn Dis. 2003;13(3):310–315.
    1. Ulasi II, Ijoma CK, Onwubere BJ, Arodiwe E, Onodugo O, Okafor C. High prevalence and low awareness of hypertension in a market population in enugu, Nigeria. Int J Hypertens. 2011;27(869675):869675.
    1. Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase AO. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr. 2010;21(1):26–31.
    1. Omuemu VO, Okojie OH, Omuemu CE. Awareness of high blood pressure status, treatment and control in a rural community in Edo State. Niger J Clin Pract. 2007;10(3):208–212.
    1. Ekwunife OI, Udeogaranya PO, Nwatu IL. Prevalence, awareness, treatment and control of hypertension in a nigerian population. Health. 2010;2(7):731–735. doi: 10.4236/health.2010.27111.
    1. Macia E, Duboz P, Gueye L. Prevalence, awareness, treatment and control of hypertension among adults 50 years and older in Dakar, Senegal. Cardiovasc J Afr. 2012;23(5):265–269. doi: 10.5830/CVJA-2011-039.
    1. Yayehd K, Damorou F, Akakpo R, Tcherou T, N’Da NW, Pessinaba S. et al.Prevalence and determinants of hypertension in Lome (Togo): results of a screening in May 2011. Ann Cardiol Angeiol. 2013;62(1):43–50. doi: 10.1016/j.ancard.2012.09.006.
    1. Maepe LM, Outhoff K. Hypertension in goldminers. S Afr Med J. 2011;102(1):30–33.
    1. Malhotra R, Puoane T, Hoyo C, Hughes G, Ostbye T. Prevalence and awareness of hypertension in an urban township of South Africa: compelling need for action. Ethn Dis. 2008;18(4):401–402. Autumn;18.
    1. Steyn K, Bradshaw D, Norman R, Laubscher R. Determinants and treatment of hypertension in South Africans: the first demographic and health survey. S Afr Med J. 2008;98(5):376–380.
    1. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M. et al.Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. Cmaj. 2011;183(9):1007–1013. doi: 10.1503/cmaj.101767.
    1. Joynt KE, Chan D, Orav EJ, Jha AK. Insurance expansion in massachusetts did not reduce access among previously insured medicare patients. Health Aff. 2013;32(3):571–578. doi: 10.1377/hlthaff.2012.1018.
    1. Atim C, Fleisher LK, Hatt L, Musau S, Arur A. Health Financing in Africa Today: Challenges and Opportunities. Washington, DC: Africa’s Health, Academy for Educational Developmen, and Bethesda, MD: Health Systems 20/20 Project; 2008.
    1. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199–1208. doi: 10.1161/01.HYP.37.5.1199.
    1. Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J. et men and women respond differently to blood pressure-lowering treatment? results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669–2680. doi: 10.1093/eurheartj/ehn427.
    1. Wilkins K, Gee M, Campbell N. The difference in hypertension control between older men and women. Health Rep. 2012;23(4):33–40.
    1. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51(4):1149–1155. doi: 10.1161/HYPERTENSIONAHA.107.107342.
    1. Mufunda E, Albin B, Hjelm K. Differences in health and illness beliefs in Zimbabwean men and women with diabetes. Open Nurs J. 2012;6:117–125.
    1. Hjelm K, Nambozi G. Beliefs about health and illness: a comparison between Ugandan men and women living with diabetes mellitus. Int Nurs Rev. 2008;55(4):434–441. doi: 10.1111/j.1466-7657.2008.00665.x.
    1. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. Journal of hypertension. 2009;27(5):963–975. doi: 10.1097/HJH.0b013e3283282f65.
    1. Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22:338–342.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다